The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up
Author
Mutlu, M.
Yapici, Z.
Kurtuncu, M.
Topcular, B.
Ozcan, H.
Durmus, Hacer
Eraksoy, M.
Akinan-Demir, G.
Metadata
Show full item recordCollections
- Bildiri [64839]